Dr. Reddy’s is one of the largest generic drug manufacturers in the world. Global generics make up over 85% of the firm's sales, and along with other generics manufacturers, it continues to ...

VIJAYAWADA: Former Defence Research and Development Organisation (DRDO) Chairman Dr G Satish Reddy officially assumed charge as Advisor for Aerospace and Defense to the Andhra Pradesh government ...

Shares of Dr. Reddy's Laboratories Ltd. 500124 slid 2.32% to 1,173.55 Indian rupees Friday, on what proved to be an all-around dismal trading session for the stock market, with the BSE SENSEX ...

Pharma major Dr. Reddy’s Laboratories has said that the Indian Income Tax Department served a show-cause notice on the company on April 4, asking it to explain why its IT returns for the ...

Kyndryl a provider of enterprise technology services, has partnered with Dr Reddy’s Laboratories to transform Dr Reddy’s IT operations across all locations including manufacturing plants ...

Shares of Dr. Reddy's Laboratories Ltd. 500124 advanced 4.21% to 1,155.80 Indian rupees Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the BSE ...

In this article, we will take a look at where Dr. Reddy’s Laboratories Limited (NYSE:RDY) stands against other best Indian stocks. India’s stock market had a rough ride during the second half ...

Dubai, UAE – Offering new hope for Parkinson’s patients, leading Radiation Oncologist of India, Dr. Lohith Reddy has successfully performed a 15-minute non-invasive CyberKnife radiosurgery to treat ...

“We are positive on these three stocks—Sun Pharma, Dr Reddy’s, and Lupin—despite the tariff announcements. India remains the ‘pharmacy of the world,’ and there’s no challenge to its ...

“Given Zydus Lifesciences and Dr Reddy’s Laboratories have high US sales exposure with ~45% and 43% sales contribution, we believe they are at highest risk among generics in our coverage ...

As many as 10,064 pregnant women have benefited from the Dr. Muthulakshmi Reddy Maternity Benefit Scheme (MRMBS) in Tiruchi city during the year 2024-25. Under the scheme, ₹18,000 is given to ...

India's Dr Reddy's Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an ...